387477005: Scopolamine hydrobromide (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Acetylcholine receptor antagonist\Muscarinic receptor antagonist\Scopolamine hydrobromide (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\...

\Antispasmodic (substance)\Scopolamine hydrobromide (substance)

\Acetylcholine receptor antagonist\Muscarinic receptor antagonist\Scopolamine hydrobromide (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Organic cyclic compound\Heterocyclic compound\...

\Tropane (substance)\Tropane alkaloid (substance)\Scopolamine hydrobromide (substance)

\Alkaloid (substance)\Tropane alkaloid (substance)\Scopolamine hydrobromide (substance)

\Aza compound (substance)\Azabicyclo compound (substance)\Tropane (substance)\Tropane alkaloid (substance)\Scopolamine hydrobromide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461655011 Scopolamine hydrobromide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481568017 Scopolamine hydrobromide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

1492108011 Hyoscine hydrobromide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

9421000188115 scopolamine bromhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Scopolamine hydrobromide (substance)	Is a	Scopolamine (substance)	false	Inferred relationship	Some
Scopolamine hydrobromide (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Muscarinic receptor antagonist (disposition)	true	Inferred relationship	Some
Scopolamine hydrobromide (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Scopolamine (substance)	true	Inferred relationship	Some
Scopolamine hydrobromide (substance)	Is a	Tropane alkaloid (substance)	true	Inferred relationship	Some
Scopolamine hydrobromide (substance)	Is a	Antispasmodic (substance)	true	Inferred relationship	Some
Scopolamine hydrobromide (substance)	Is a	Muscarinic receptor antagonist	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Hyoscine hydrobromide adverse reaction	Causative agent (attribute)	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Hyoscine hydrobromide allergy	Causative agent (attribute)	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Scopolamine hydrobromide 0.25% solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Hyoscine hydrobromide 400 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Scopolamine hydrobromide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Hyoscine hydrobromide 0.25% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Hyoscine hydrobromide 0.125% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Hyoscine hydrobromide 0.5% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Hyoscine hydrobromide [eye]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Ophthalmic hyoscine hydrobromide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Product containing atropine sulfate and hyoscyamine sulfate and scopolamine hydrobromide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Hyoscine hydrobromide 1mg/72hours transdermal patch	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Product containing papaveretum and scopolamine hydrobromide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Hyoscine hydrobromide 150 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Hyoscine hydrobromide 400micrograms/mL injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Hyoscine hydrobromide 600micrograms/mL injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Hyoscine hydrobromide [central nervous system use]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Hyoscine hydrobromide [anesthesia]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Hyoscine hydrobromide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Product containing scopolamine hydrobromide in parenteral dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Product containing scopolamine hydrobromide in transdermal dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Hyoscine hydrobromide allergy	Causative agent (attribute)	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some	2
Scopolamine hydrobromide trihydrate (substance)	Is a	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Hyoscine hydrobromide 150 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Hyoscine hydrobromide 150 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Hyoscine hydrobromide 400 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Hyoscine hydrobromide 400 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some	2
Scopolamine hydrobromide trihydrate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some
Hyoscine hydrobromide 150 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely scopolamine hydrobromide 300 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Hyoscine hydrobromide 400 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some	2
Product containing precisely scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection ampule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely scopolamine hydrobromide 600 microgram/1 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely scopolamine hydrobromide 600 microgram/1 milliliter conventional release solution for injection ampule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection ampule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely scopolamine hydrobromide 600 microgram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely scopolamine hydrobromide 600 microgram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some	2
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Scopolamine hydrobromide (substance)	Inferred relationship	Some	2
Hyoscine (as hyoscine hydrobromide) 1.25 mg/mL eye solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely scopolamine (as scopolamine hydrobromide) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Hyoscine (as hyoscine hydrobromide) 5 mg/mL eye solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Hyoscine hydrobromide adverse reaction	Causative agent (attribute)	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some	1
Scopolamine hydrobromide anhydrous (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Scopolamine hydrobromide (substance)	Inferred relationship	Some

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461655011	Scopolamine hydrobromide (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481568017	Scopolamine hydrobromide	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1492108011	Hyoscine hydrobromide	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
9421000188115	scopolamine bromhydrate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module